Home ETF List About

Portfolio Holdings Detail for ISIN IE0002EKOXU6
Stock Name / FundiShares Russell 1000 Value UCITS ETF
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerR1VL(USD) LSE
ETF TickerR1VL.AS(USD) Euronext Amsterdam
ETF TickerR1VL.L(GBP) LSE

Holdings detail for QGEN

Stock NameQiagen NV
TickerQGEN(USD) NYSE
TYPECommon Stock
CountryUSA
ISINNL0015001WM6
LEI54930036WK3GMCN17Z57

Show aggregate QGEN holdings

News associated with QGEN

QIAGEN N.V. (NYSE:QGEN) Receives $49.69 Consensus Target Price from Analysts
QIAGEN N.V. (NYSE:QGEN – Get Free Report) has received a consensus rating of “Hold” from the eleven brokerages that are covering the firm, MarketBeat reports. Eight equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month price target among analysts that […] - 2025-09-19 02:43:08
William Blair Forecasts QIAGEN’s Q2 Earnings (NYSE:QGEN)
QIAGEN N.V. (NYSE:QGEN – Free Report) – Analysts at William Blair dropped their Q2 2026 earnings per share estimates for QIAGEN in a research note issued to investors on Thursday, August 7th. William Blair analyst A. Brackmann now anticipates that the company will post earnings of $0.62 per share for the quarter, down from their […] - 2025-08-12 05:26:53
Federated Hermes Inc. Takes Position in Qiagen N.V. (NYSE:QGEN)
Federated Hermes Inc. acquired a new stake in Qiagen N.V. (NYSE:QGEN – Free Report) in the first quarter, HoldingsChannel.com reports. The fund acquired 3,739 shares of the company’s stock, valued at approximately $150,000. A number of other hedge funds also recently made changes to their positions in QGEN. LPL Financial LLC lifted its position in […] - 2025-08-11 04:48:50
Qiagen (NYSE:QGEN) Cut to Buy at Wall Street Zen
Qiagen (NYSE:QGEN – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a report issued on Monday. A number of other research firms also recently weighed in on QGEN. Robert W. Baird raised their target price on shares of Qiagen from $42.00 to […] - 2025-08-11 02:22:52
Qiagen (NYSE:QGEN) Stock Rating Upgraded by Wall Street Zen
Qiagen (NYSE:QGEN – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued on Sunday. Other research analysts also recently issued reports about the company. Robert W. Baird upped their price objective on Qiagen from $42.00 to $43.00 and gave […] - 2025-08-05 02:43:13
New York State Common Retirement Fund Acquires 3,623 Shares of QIAGEN N.V. (NYSE:QGEN)
New York State Common Retirement Fund raised its holdings in QIAGEN N.V. (NYSE:QGEN – Free Report) by 3.0% in the first quarter, HoldingsChannel.com reports. The firm owned 125,126 shares of the company’s stock after purchasing an additional 3,623 shares during the quarter. New York State Common Retirement Fund’s holdings in QIAGEN were worth $5,024,000 as […] - 2025-07-22 07:09:12
Signaturefd LLC Sells 10,326 Shares of Qiagen N.V. (NYSE:QGEN)
Signaturefd LLC reduced its position in shares of Qiagen N.V. (NYSE:QGEN – Free Report) by 75.5% in the first quarter, Holdings Channel reports. The firm owned 3,354 shares of the company’s stock after selling 10,326 shares during the period. Signaturefd LLC’s holdings in Qiagen were worth $135,000 at the end of the most recent reporting […] - 2025-07-21 05:09:43
Bank of New York Mellon Corp Sells 41,846 Shares of Qiagen N.V. (NYSE:QGEN)
Bank of New York Mellon Corp cut its holdings in Qiagen N.V. (NYSE:QGEN – Free Report) by 4.5% in the 1st quarter, Holdings Channel reports. The institutional investor owned 882,919 shares of the company’s stock after selling 41,846 shares during the period. Bank of New York Mellon Corp’s holdings in Qiagen were worth $35,449,000 as […] - 2025-07-15 05:08:56
Qiagen N.V. (NYSE:QGEN) Receives Consensus Rating of “Hold” from Analysts
Qiagen N.V. (NYSE:QGEN – Get Free Report) has received a consensus rating of “Hold” from the ten brokerages that are presently covering the stock, Marketbeat.com reports. Seven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month target price among brokerages […] - 2025-07-03 02:56:48
Illinois Municipal Retirement Fund Sells 1,787 Shares of Qiagen N.V. (NYSE:QGEN)
Illinois Municipal Retirement Fund cut its holdings in shares of Qiagen N.V. (NYSE:QGEN – Free Report) by 2.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 62,531 shares of the company’s stock after selling 1,787 shares during the quarter. […] - 2025-06-30 05:14:52
Qiagen (NYSE:QGEN) Earns Overweight Rating from Analysts at Barclays
Stock analysts at Barclays began coverage on shares of Qiagen (NYSE:QGEN – Get Free Report) in a research note issued on Tuesday, MarketBeat Ratings reports. The firm set an “overweight” rating and a $55.00 price target on the stock. Barclays‘s price objective would indicate a potential upside of 15.84% from the stock’s current price. A […] - 2025-06-26 02:48:52
Blue Trust Inc. Acquires 3,157 Shares of QIAGEN N.V. (NYSE:QGEN)
Blue Trust Inc. grew its holdings in QIAGEN N.V. (NYSE:QGEN – Free Report) by 30.5% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,519 shares of the company’s stock after acquiring an additional 3,157 shares during the period. Blue Trust Inc.’s holdings in […] - 2025-06-22 05:22:57
Qiagen (NYSE:QGEN) Shares Sold by Rhumbline Advisers
Rhumbline Advisers decreased its stake in Qiagen (NYSE:QGEN – Free Report) by 5.4% during the 1st quarter, HoldingsChannel reports. The firm owned 194,303 shares of the company’s stock after selling 11,088 shares during the period. Rhumbline Advisers’ holdings in Qiagen were worth $7,801,000 as of its most recent filing with the Securities and Exchange Commission. […] - 2025-06-11 05:54:44
Brokerages Set Qiagen (NYSE:QGEN) Target Price at $48.42
Qiagen (NYSE:QGEN – Get Free Report) has earned an average recommendation of “Hold” from the ten ratings firms that are covering the stock, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target among brokerages […] - 2025-06-11 02:22:44
Tidal Investments LLC Buys 7,815 Shares of Qiagen (NYSE:QGEN)
Tidal Investments LLC grew its stake in Qiagen (NYSE:QGEN – Free Report) by 72.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,559 shares of the company’s stock after acquiring an additional 7,815 shares during the period. Tidal Investments […] - 2025-05-27 05:21:01
Fund Update: STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM Just Disclosed New Holdings
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 03-31-2025 report period. You can see the full portfolio on Quiver Quantitative, and track move - 2025-05-12 14:42:21
Qiagen (NYSE:QGEN) Holdings Lifted by Tower Research Capital LLC TRC
Tower Research Capital LLC TRC boosted its holdings in Qiagen (NYSE:QGEN – Free Report) by 770.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,490 shares of the company’s stock after acquiring an additional 2,204 shares during the quarter. Tower […] - 2025-05-09 05:55:01
Qiagen (NYSE:QGEN) Upgraded to “Strong-Buy” at StockNews.com
Qiagen (NYSE:QGEN – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued on Friday. QGEN has been the subject of several other reports. Baird R W cut Qiagen from a “strong-buy” rating to a “hold” rating in a research note on […] - 2025-05-09 04:56:48
Fund Update: DekaBank Deutsche Girozentrale Just Disclosed New Holdings
DekaBank Deutsche Girozentrale just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 03-31-2025 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-04-30 10:18:17
Zacks Research Weighs in on Qiagen’s Q3 Earnings (NYSE:QGEN)
Qiagen (NYSE:QGEN – Free Report) – Equities research analysts at Zacks Research dropped their Q3 2025 earnings per share (EPS) estimates for shares of Qiagen in a research report issued on Thursday, April 24th. Zacks Research analyst R. Department now expects that the company will earn $0.57 per share for the quarter, down from their […] - 2025-04-29 02:54:55
LPL Financial LLC Boosts Stake in Qiagen (NYSE:QGEN)
LPL Financial LLC grew its holdings in Qiagen (NYSE:QGEN – Free Report) by 2.6% during the fourth quarter, HoldingsChannel reports. The firm owned 17,240 shares of the company’s stock after acquiring an additional 432 shares during the period. LPL Financial LLC’s holdings in Qiagen were worth $768,000 at the end of the most recent reporting […] - 2025-04-23 04:18:46
Brokerages Set Qiagen (NYSE:QGEN) Target Price at $47.71
Shares of Qiagen (NYSE:QGEN – Get Free Report) have received a consensus recommendation of “Hold” from the eleven research firms that are currently covering the firm, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month […] - 2025-04-22 02:35:00
Analysts See 22% Gains Ahead For The Holdings of JQUA
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-04 08:08:22
QIAGEN Unveils QIAprep& Plasmodium Kit For Malaria Detection And Surveillance
(RTTNews) - QIAGEN N.V. (QGEN) has unveiled the QIAprep& Plasmodium Kit along with two companion assays to enhance efforts in malaria research and monitoring. This innovative solution streamlines sample preparation and quantitative PCR (qPCR) into a unified workflow, enabling fas - 2025-04-01 02:45:40
Qiagen (NYSE:QGEN) Receives $47.71 Average PT from Analysts
Shares of Qiagen (NYSE:QGEN – Get Free Report) have been assigned a consensus rating of “Hold” from the ten analysts that are presently covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month target price […] - 2025-03-03 04:32:49
QIAGEN Files Patent Complaint Against BioMérieux To Protect QuantiFERON Technology
(RTTNews) - QIAGEN N.V. (QGEN) announced that it has filed a complaint against bioMrieux S.A. for patent infringement, reinforcing its commitment to protecting the scientific advancements behind its proprietary QuantiFERON technology. - 2025-03-03 04:16:07
Qiagen (NYSE:QGEN) Stock Rating Lowered by Robert W. Baird
Qiagen (NYSE:QGEN – Get Free Report) was downgraded by Robert W. Baird from an “outperform” rating to a “neutral” rating in a research report issued to clients and investors on Wednesday, MarketBeat reports. They currently have a $42.00 price target on the stock, down from their prior price target of $52.00. Robert W. Baird’s price […] - 2025-02-21 06:42:50
Qiagen (NYSE:QGEN) Reaches New 1-Year Low Following Analyst Downgrade
Qiagen (NYSE:QGEN – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Monday after UBS Group lowered their price target on the stock from $50.00 to $48.00. UBS Group currently has a neutral rating on the stock. Qiagen traded as low as $39.63 and last traded at $39.97, with a […] - 2025-02-12 04:14:58
GUSA's Holdings Imply 13% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-01-30 10:31:11
Fund Update: DekaBank Deutsche Girozentrale Just Disclosed New Holdings
DekaBank Deutsche Girozentrale just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-01-29 12:02:12

iShares Russell 1000 Value UCITS ETF QGEN holdings

DateNumber of QGEN Shares HeldBase Market Value of QGEN SharesLocal Market Value of QGEN SharesChange in QGEN Shares HeldChange in QGEN Base ValueCurrent Price per QGEN Share HeldPrevious Price per QGEN Share Held
2025-11-10 (Monday)1,719USD 74,209QGEN holding decreased by -671USD 74,2090USD -671 USD 43.1699 USD 43.5602
2025-11-07 (Friday)1,719USD 74,880QGEN holding increased by 860USD 74,8800USD 860 USD 43.5602 USD 43.0599
2025-11-06 (Thursday)1,719USD 74,020QGEN holding decreased by -1702USD 74,0200USD -1,702 USD 43.0599 USD 44.05
2025-11-05 (Wednesday)1,719QGEN holding increased by 26USD 75,722QGEN holding increased by 959USD 75,72226USD 959 USD 44.05 USD 44.1601
2025-11-04 (Tuesday)1,693USD 74,763QGEN holding decreased by -2573USD 74,7630USD -2,573 USD 44.1601 USD 45.6799
2025-11-03 (Monday)1,693USD 77,336QGEN holding decreased by -1981USD 77,3360USD -1,981 USD 45.6799 USD 46.85
2025-10-31 (Friday)1,693QGEN holding increased by 26USD 79,317QGEN holding increased by 2085USD 79,31726USD 2,085 USD 46.85 USD 46.3299
2025-10-30 (Thursday)1,667USD 77,232QGEN holding decreased by -1434USD 77,2320USD -1,434 USD 46.3299 USD 47.1902
2025-10-29 (Wednesday)1,667USD 78,666QGEN holding decreased by -1267USD 78,6660USD -1,267 USD 47.1902 USD 47.9502
2025-10-28 (Tuesday)1,667USD 79,933QGEN holding decreased by -750USD 79,9330USD -750 USD 47.9502 USD 48.4001
2025-10-27 (Monday)1,667USD 80,683QGEN holding decreased by -1533USD 80,6830USD -1,533 USD 48.4001 USD 49.3197
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of QGEN by Blackrock for IE0002EKOXU6

Show aggregate share trades of QGEN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-05BUY2644.62043.420 43.540USD 1,132 43.73
2025-10-31BUY2647.23046.190 46.294USD 1,204 43.70
2025-10-22BUY2648.60048.890 48.861USD 1,270 43.52
2025-10-21SELL-39348.55049.590 49.486USD -19,448 43.49 Loss of -2,355 on sale
2025-10-14BUY9647.50047.570 47.563USD 4,566 43.36
2025-09-30BUY6244.68045.070 45.031USD 2,792 43.30
2025-08-04BUY2350.25050.270 50.268USD 1,156 43.21
2025-06-27SELL-45347.77048.290 48.238USD -21,852 42.32 Loss of -2,683 on sale
2025-06-18SELL-3146.55046.810 46.784USD -1,450 42.07 Loss of -146 on sale
2025-06-02SELL-6244.90045.210 45.179USD -2,801 41.75 Loss of -212 on sale
2025-05-27SELL-3143.85044.080 44.057USD -1,366 41.66 Loss of -74 on sale
2025-05-21BUY34142.32043.010 42.941USD 14,643 41.64
2025-05-12BUY3042.96042.970 42.969USD 1,289 41.59
2025-05-08BUY12042.16043.050 42.961USD 5,155 41.58
2025-04-30BUY3042.75043.190 43.146USD 1,294 41.52
2025-04-28SELL-3042.47042.600 42.587USD -1,278 41.50 Loss of -33 on sale
2025-04-22BUY6042.34042.550 42.529USD 2,552 41.46
2025-04-16BUY3041.44041.800 41.764USD 1,253 41.49
2025-04-09BUY9041.43041.650 41.628USD 3,747 41.49
2025-04-04SELL-12038.26039.740 39.592USD -4,751 41.58 Profit of 238 on sale
2025-04-02BUY6040.02040.190 40.173USD 2,410 41.60
2025-03-31BUY3040.15040.270 40.258USD 1,208 41.64
2025-03-27BUY15039.65039.810 39.794USD 5,969 41.69
2025-02-24BUY3139.91040.100 40.081USD 1,243 42.65
2025-02-12BUY3040.14040.400 40.374USD 1,211 43.15
2025-02-10BUY6040.08040.470 40.431USD 2,426 43.30
2025-02-05BUY3043.80044.030 44.007USD 1,320 43.36
2025-01-29SELL-2543.77044.860 44.751USD -1,119 43.27 Loss of -37 on sale
2025-01-02BUY23744.52044.910 44.871USD 10,634 42.96
2024-11-18BUY6940.99041.200 41.179USD 2,841 42.70
2024-11-08BUY2343.76044.270 44.219USD 1,017 42.59
2024-11-06BUY4643.87044.060 44.041USD 2,026 42.35
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of QGEN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19160,214170277,18657.8%
2025-09-18161,540330238,49567.7%
2025-09-17121,109817243,80249.7%
2025-09-16113,2421271,69441.7%
2025-09-15138,5560336,81941.1%
2025-09-12211,1950348,67160.6%
2025-09-11250,3311,706439,85156.9%
2025-09-10104,0380199,30852.2%
2025-09-09131,4840253,70151.8%
2025-09-08141,6370242,82258.3%
2025-09-05145,852490289,11450.4%
2025-09-04134,564307243,66455.2%
2025-09-03290,0190586,41549.5%
2025-09-02374,9115676,39755.4%
2025-08-29267,18470498,08553.6%
2025-08-28981,30201,769,63955.5%
2025-08-2761,467150225,49827.3%
2025-08-26103,6410298,53834.7%
2025-08-2593,4160152,53561.2%
2025-08-22150,212444287,54752.2%
2025-08-21133,93136208,19164.3%
2025-08-20214,15780349,13961.3%
2025-08-19182,0851,528389,50746.7%
2025-08-18233,02579562,27641.4%
2025-08-15174,487921289,41960.3%
2025-08-14185,1270248,55874.5%
2025-08-13143,4670270,40953.1%
2025-08-12157,2821,101264,48559.5%
2025-08-11199,705160364,45854.8%
2025-08-08213,4280319,51966.8%
2025-08-07474,4800567,55083.6%
2025-08-06484,617740738,89265.6%
2025-08-05247,635384616,56340.2%
2025-08-04337,8643,141511,35566.1%
2025-08-01246,121840394,59762.4%
2025-07-31199,514280427,25746.7%
2025-07-30187,6591,700311,74360.2%
2025-07-29168,417570301,84255.8%
2025-07-28228,983186426,07253.7%
2025-07-25275,7130358,66276.9%
2025-07-24232,430729324,28671.7%
2025-07-23420,99612,314555,83375.7%
2025-07-22425,0872,089475,35489.4%
2025-07-21411,48620502,18181.9%
2025-07-18727,789410798,57191.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.